Rite Aid Pharmacy #04515 Durable Medical Equipment & Medical Supplies Location: 3251 South Blvd, Auburn Hills, Michigan 48326 Phone: (248) 852-5977 |
Cvs Pharmacy #16599 Durable Medical Equipment & Medical Supplies Location: 650 Brown Rd, Auburn Hills, Michigan 48326 Phone: (248) 393-8114 |
Rite Aid Pharmacy #04338 Durable Medical Equipment & Medical Supplies Location: 2480 Lapeer Rd, Auburn Hills, Michigan 48326 Phone: (248) 373-7700 |
Care Plus Cvs/pharmacy #02953 Durable Medical Equipment & Medical Supplies Location: 800 Chrysler Dr, Auburn Hills, Michigan 48326 Phone: (248) 944-1638 |
Sam's Pharmacy 10-4778 Durable Medical Equipment & Medical Supplies Location: 4350 Joslyn Rd, Auburn Hills, Michigan 48326 Phone: (248) 391-6697 |
Meijer Pharmacy#185 Durable Medical Equipment & Medical Supplies Location: 800 Brown Rd, Auburn Hills, Michigan 48326 Phone: (248) 393-5110 |
News Archive
Oncolytics Biotech Inc. today announced that it has been granted its 35th U.S. Patent, # 7,731,951 entitled "Viruses for the Treatment of Cellular Proliferative Disorders." The patent claims cover methods for treating cell proliferative disorders by administering modified vaccinia virus to proliferating cells having an activated Ras-pathway.
A pregnant woman's immune response to viral infections may induce subtle neurological changes in the unborn child that can lead to an increased risk for neurodevelopmental disorders including schizophrenia and autism. Research published in the online journal mBio- provides new insights into how this may happen and suggests potential strategies for reducing this risk.
VentiRx Pharmaceuticals, Inc., a biopharmaceutical company focused on the development of novel Toll-Like Receptor 8 (TLR8) candidates for the treatment of cancer, respiratory and inflammatory diseases, announced today results from its randomized, placebo controlled clinical trial evaluating VTX-1463 for the treatment of allergic rhinitis.
Echo Therapeutics, Inc., a medical device company, today announced its financial results for the quarter ended September 30, 2014.
› Verified 4 days ago